Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Практическая пульмонология (ранее – "Атмосфера. Пульмонология и аллергология"): ISSN 2409-756X (Online), ISSN 2409-6636 (Print)
2019 / N 2

Перспективы клеточных технологий в лечении идиопатического легочного фиброза
А.В. Аверьянов, А.Г. Сотникова

References

1. Duchemann B, Annesi-Maesano I, Jacobe de Naurois C, Sanyal S, Brillet PY, Brauner M, Kambouchner M, Huynh S, Naccache JM, Borie R, Piquet J, Mekinian A, Virally J, Uzunhan Y, Cadranel J, Crestani B, Fain O, Lhote F, Dhote R, Saidenberg-Kermanac’h N, Rosental PA, Valeyre D, Nunes H. Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris. The European Respiratory Journal 2017 Aug;50(2). pii: 1602419. doi: 10.1183/13993003.02419-2016. Print 2017 Aug.
2. Thomeer M, Demedts M, Vandeurzen K; VRGT Working Group on Interstitial Lung Diseases. Registration of interstitial lung diseases by 20 centres of respiratory medicine in flanders. Acta Clinica Belgica 2001 May-Jun;56(3):163-72.
3. Vancheri C, Failla M, Crimi N, Raghu G. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. The European Respiratory Journal 2010 Mar;35(3):496-504.
4. Toonkel RL, Hare JM, Matthay MA, Glassberg MK. Mesenchymal stem cells and idiopathic pulmonary fibrosis: potential for clinical testing. American Journal of Respiratory and Critical Care Medicine 2013 Jul;188(2):133-40.
5. Gol'dberg ED, Dygai AM, Zhdanov VV. Modern views on the problem of stem cells and potentialities of their use in medicine. Bulletin of Experimental Biology and Medicine 2005 Nov;140(5):588-92.
6. Mimeault M, Hauke R, Batra SK. Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clinical Pharmacology & Therapeutics2007 Sep;82(3):252-64.
7. Aliotta JM, Passero M, Meharg J, Klinger J, Dooner MS, Pimentel J, Quesenberry PJ. Stem cells and pulmonary metamorphosis: new concepts in repair and regeneration. Journal of Cellular Physiology 2005 Sep;204(3):725-41.
8. Wang G, Bunnell BA, Painter RG, Quiniones BC, Tom S, Lanson NA Jr, Spees JL, Bertucci D, Peister A, Weiss DJ, Valentine VG, Prockop DJ, Kolls JK. Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis. Proceedings of the National Academy of Sciences of the USA 2005 Jan;102(1):186-91.
9. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, Neutzel S, Sharkis SJ. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001 May;105(3):369-77.
10. Wecht S, Rojas M. Mesenchymal stem cells in the treatment of chronic lung disease. Respirology (Carlton, Vic.) 2016 Nov;21(8):1366-75.
11. Weiss DJ, Bertoncello I, Borok Z, Kim C, Panoskaltsis-Mortari A, Reynolds S, Rojas M, Stripp B, Warburton D, Prockop DJ. Stem cells and cell therapies in lung biology and lung diseases. Proceedings of the American Thoracic Society 2011 Jun;8(3):223-72.
12. Liu M, Ren D, Wu D, Zheng J, Tu W. Stem cell and idiopathic pulmonary fibrosis: mechanisms and treatment. Current Stem Cell Research & Therapy 2015;10(6):466-76.
13. Ortiz LA, DuTreil M, Fattman C, Pandey AC, Torres G, Go K, Phinney DG. Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proceedings of the National Academy of Sciences of the USA 2007 Jun;104(26):11002-7.
14. Cahill EF, Kennelly H, Carty F, Mahon BP, English K. Hepatocyte growth factor is required for mesenchymal stromal cell protection against bleomycin-induced pulmonary fibrosis stem cells. Stem Cells Translational Medicine 2016 Oct;5(10):1307-18.
15. Wang X, Gao JL, Zhao MM, Zhu HX, Tian YX, Li R, Jiang XH, Yu L, Tian JR, Cui JZ. Therapeutic effects of conditioned medium from bone marrow-derived mesenchymal stem cells on epithelial-mesenchymal transition in A549 cells. International Journal of Molecular Medicine 2018 Feb;41(2):659-68.
16. Li X, Yue S, Luo Z. Mesenchymal stem cells in idiopathic pulmonary fibrosis. Oncotarget 2017 May;8(60):102600-16.
17. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Experimental Hematology 2003 Oct;31(10):890-6.
18. Moodley Y, Atienza D, Manuelpillai U, Samuel CS, Tchongue J, Ilancheran S, Boyd R, Trounson A. Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. The American Journal of Pathology 2009 Jul;175(1):303-13.
19. Kumamoto M, Nishiwaki T, Matsuo N, Kimura H, Matsushima K. Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury. The European Respiratory Journal 2009 Sep;34(3):740-8.
20. Srour N, Thébaud B. Mesenchymal stromal cells in animal bleomycin pulmonary fibrosis models: a systematic review. Stem Cells Translational Medicine 2015 Dec;4(12):1500-10.
21. Reddy M, Fonseca L, Gowda S, Chougule B, Hari A, Totey S. Human adipose-derived mesenchymal stem cells attenuate early stage of bleomycin induced pulmonary fibrosis: comparison with pirfenidone. International Journal of Stem Cells 2016 Nov;9(2):192-206.
22. Averyanov AV, Konoplyannikov AG, Zabozlayev FG, Sotnikova AG, Danilevskaya OV, Konoplyannikov MA, Tatarskiy AR. Comparative study of the effects of mesenchymal stem cells in different delivery methods in an experimental model of pulmonary fibrosis. Journal of Clinical Practice 2018;9(4):4-14 (In Russian).
23. Moeller A, Gilpin SE, Ask K, Cox G, Cook D, Gauldie J, Margetts PJ, Farkas L, Dobranowski J, Boylan C, O’Byrne PM, Strieter RM, Kolb M. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine 2009 Apr;179(7):588-94.
24. Andersson-Sjöland A, de Alba CG, Nihlberg K, Becerril C, Ramírez R, Pardo A, Westergren-Thorsson G, Selman M. Fibrocytes are a potential source of lung fibroblasts in idiopatic pulmonary fibrosis. The International Journal of Biochemistry & Cell Biology 2008;40(10):2129-40.
25. Badri L, Murray S, Liu LX, Walker NM, Flint A, Wadhwa A, Chan KM, Toews GB, Pinsky DJ, Martinez FJ, Lama VN. Mesenchymal stromal cells in bronchoalveolar lavage as predictors of bronchiolitis obliterans syndrome. American Journal of Respiratory and Critical Care Medicine 2011 Apr;183(8):1062-70.
26. Ntolios P, Janes SM. Mesenchymal stem cell therapy for lung diseases: oasis or mirage? Respiration 2013;85(4):279-80.
27. Simonson OE, Domogatskaya A, Volchkov P, Rodin S. The safety of human pluripotent stem cells in clinical treatment. Annals of Medicine 2015;47(5):370-80.
28. Kursova LV, Konoplyanikov AG, Pasov VV, Ivanova IN, Poluektova MV, Konoplyannikova OA. Autologous mesenchymal stem cells in treatment of radiation-induced lung injuries. Cell Technologies in Biology and Medicine 2009;6(2):108-12 (In Russian).
29. Tzouvelekis A, Paspaliaris V, Koliakos G, Ntolios P, Bouros E, Oikonomou A, Zissimopoulos A, Boussios N, Dardzinski B, Gritzalis D, Antoniadis A, Froudarakis M, Kolios G, Bouros D. A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis. Journal of Translational Medicine 2013 Jul;11:171.
30. Ntolios P, Manoloudi E, Tzouvelekis A, Bouros E, Steiropoulos P, Anevlavis S, Bouros D, Froudarakis ME. Longitudinal outcomes of patients enrolled in a phase Ib clinical trial of the adipose-derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis. The Clinical Respiratory Journal 2018 Jun;12(6):2084-9.
31. Chambers DC, Enever D, Ilic N, Sparks L, Whitelaw K, Ayres J, Yerkovich ST, Khalil D, Atkinson KM, Hopkins PM. A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis. Respirology (Carlton, Vic.) 2014 Oct;19(7):1013-8.
32. Glassberg MK, Minkiewicz J, Toonkel RL, Simonet ES, Rubio GA, DiFede D, Shafazand S, Khan A, Pujol MV, LaRussa VF, Lancaster LH, Rosen GD, Fishman J, Mageto YN, Mendizabal A, Hare JM. Allogeneic human mesenchymal stem cells in patients with idiopathic pulmonary fibrosis via intravenous delivery (AETHER): a phase I safety clinical trial. Chest 2017 May;151(5):971-81.
33. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, Cottin V, Flaherty KR, Hansell DM, Inoue Y, Kim DS, Kolb M, Nicholson AG, Noble PW, Selman M, Taniguchi H, Brun M, Le Maulf F, Girard M, Stowasser S, Schlenker-Herceg R, Disse B, Collard HR; INPULSIS Trial Investigators. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. The New England Journal of Medicine 2014 May;370(22):2071-82.
34. Averyanov A, Koroleva I, Sotnikova A, Konoplyannikov M, Lesnyak V, Danilevskaya O, Baklaushev V. Safety and efficacy of transplantation of high cumulative dose allogeneic bone marrow-derived mesenchymal stem cells in patients with idiopathic pulmonary fibrosis and rapid lung function decline. American Journal of Respiratory and Critical Care Medicine 2019;199:A2640.
  

[ Содержание выпуска N 2 | Выпуски журнала | Список журналов ]